VTv Therapeutics (VTVT) Stock Highlights

15.46 | -5.9%

2024-11-21 06:21:55

vTv Therapeutics Inc operates in the United States healthcare sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimers disease. Its major drug candidate to treat Alzheimers is azeliragon (TTP488), an orally administered drug. Its other products include TTP399, type II diabetes drug candidate. TTP399 is also an orally administered drug that targets the glucagon-like peptide-1 receptor. It also has over three additional programs in various stages of clinical development for the prevention of muscle weakness and the treatment of inflammatory disorders.

Statistics

Range Today

15.46 16.81

Volume Today 16.3K

Range 1 Year

7.38 30.99

Volume 1 Year 9.67M

Range 3 Year

7.38 57.6

Volume 3 Year 12.92M

Range 10 Year

7.38 560

Volume 10 Year 53.37M

Highlights

Market Capitalization 32.84M (micro)

Floating Shares 883.71K

Current Price 15.46

Price To Earnings -1.98

Price To Revenue -8.53

Price To Book 1.99

Earnings Per Share -6.83

Payout Ratio 0%

Performance

Latest -5.9%

1 Month +9.72%

3 Months -2.21%

6 Months -43.9%

1 Year +1.71%

3 Years -73.16%

5 Years -74.9%

10 Years -97.24%

Benchmarks

Market Capitalization

334 / 368

Gross Profits

160 / 278

Total Revenue

285 / 300

Total Rank

64 / 368

Free Cashflow

39 / 352

Performance 5 years

219 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.